{"id": "1373083317227114499", "creation": 1616203548.0, "user_id": "1035185028152614913", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 15, "reply_count": 0, "like_count": 26, "quote_count": 2}}, "text": "#Cuba sends second #COVID19 #vaccine, ABDALA, into phase 3 trials after regulatory approval. Dr. Marta Ayala, General Director of the Genetic Engineering and Biotech Center in Havana, talks with MEDICC Review. @CIGBCuba @BioCubaFarma @richardhorton1 \nhttps://t.co/iy3uHQaex9", "first_save": 1634559108.199414, "hashtags": ["#CUBA", "#COVID19", "#VACCINE"]}